Skip to content
Corveus Medical logo

Corveus Medical

Corveus Medical is a YC Winter 2022 (W22) company. Based in Houston, TX, USA. Team of 3.

  • Medical Devices

About Corveus Medical

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Corveus Medical is developing a catheter-based device that treats chronic heart failure by ablating specific nerves in the upper abdomen to interrupt the pathological signaling that drives disease progression. The device targets a precise area and confirms successful ablation, addressing cardiologists' concerns about collateral tissue damage that limits existing ablation procedures. It offers a minimally invasive option for congestive heart failure patients who remain symptomatic despite standard medical therapy.

Go-to-market

Cardiologists are the target users, reached through a medtech clinical and regulatory pathway typical of catheter-based cardiac devices.

From the Y Combinator listing

How Corveus Medical describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Catheter-based solution to treat chronic heart failure.

Our device catheter-based device is able to safely perform a targeted nerve ablation in the upper abdomen. Cardiologists are concerned about collateral tissue damage in ablation procedures - our probe not only targets a very specific area, but also confirms that it’s done correctly.

Facts

Industry
Healthcare / Healthcare -> Medical Devices
Location
Houston, TX, USA
Team size
3
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works